Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Operating Expenses (2016 - 2020)

Historic Operating Expenses for Phio Pharmaceuticals (PHIO) over the last 9 years, with Q4 2020 value amounting to $2.5 million.

  • Phio Pharmaceuticals' Operating Expenses fell 775.57% to $2.5 million in Q4 2020 from the same period last year, while for Sep 2021 it was $2.5 million, marking a year-over-year decrease of 7264.44%. This contributed to the annual value of $11.5 million for FY2022, which is 1516.54% down from last year.
  • Per Phio Pharmaceuticals' latest filing, its Operating Expenses stood at $2.5 million for Q4 2020, which was down 775.57% from $2.3 million recorded in Q3 2020.
  • In the past 5 years, Phio Pharmaceuticals' Operating Expenses registered a high of $7.1 million during Q1 2017, and its lowest value of $1.5 million during Q3 2018.
  • Moreover, its 5-year median value for Operating Expenses was $2.2 million (2016), whereas its average is $2.4 million.
  • As far as peak fluctuations go, Phio Pharmaceuticals' Operating Expenses soared by 21401.33% in 2017, and later plummeted by 6805.54% in 2018.
  • Quarter analysis of 5 years shows Phio Pharmaceuticals' Operating Expenses stood at $2.3 million in 2016, then decreased by 14.24% to $2.0 million in 2017, then fell by 13.56% to $1.7 million in 2018, then surged by 53.92% to $2.7 million in 2019, then decreased by 7.76% to $2.5 million in 2020.
  • Its Operating Expenses stands at $2.5 million for Q4 2020, versus $2.3 million for Q3 2020 and $1.7 million for Q2 2020.